Local antibiotic delivery systems: Where are we and where are we going?

Clinical Orthopaedics and Related Research

Volumn 437, Issue , 2005, Pages 111-114

  Hanssen, Arlen D ^a,b   Osmon, Douglas R ^a   Patel, Robin ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BIOMATERIAL; BONE CEMENT; CEFAMANDOLE; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; RIFAMPICIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BIOFILM; BONE REGENERATION; CONFERENCE PAPER; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG TISSUE LEVEL; DRUG USE; HUMAN; INFECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 23244461214     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000175122.50804.ce     Document Type: Conference Paper

References (32)

1. Anglen J: The clinical use of bone stimulators. J South Orthop Assoc 12:46-54, 2003.
2. Anwar H, Strap JL, Costerton JW: Eradication of biofilm cells of Staphylococcus aureus with tobramycin and cephalexin. Can J Microbiol 38:618-625, 1992.
3. Benson DE, Grissom CB, Burns GL, Mohammad SF: Magnetic field enhancement of antibiotic activity in biofilm forming Pseudomonas aeruginosa. ASAIO J 40:M371-M376, 1994.
4. Carmen JC, Roeder BL, Nelson JL, et al: Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo. J Biomat Appl 18:237-245, 2004.
5. Cierny III G: Infected tibial nonunions (1981-1995). The evolution of change. Clin Orthop 360:97-105, 1999.
6. Costerton W, Veeh R, Shirtliff M, et al: The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112:1466-1477, 2003.
7. Delissalde F, Amabile-Cuevas CF: Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 24:405-408, 2004.
8. Donlan RM: Role of biofilms in antimicrobial resistance. ASAIO J 46:S47-S52, 2000.
9. Donlan RM, Costerton JW: Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167-193, 2002.
10. Gagnon RF, Richards GK, Wiesenfeld L: Staphylococcus epidermidis biofilms: Unexpected outcome of double and triple antibiotic combinations with rifampin. ASAIO Trans 37:M158-M160, 1991.
11. Gitelis S, Brebach GT: The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg (Hong Kong) 10:53-60, 2002.
12. Gracia E, Lacleriga A, Monzon M, et al: Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms. J Surg Res 79:146-153, 1998.
13. Gristina AG, Shibata Y, Giridhar G, Kreger A, Myrvik QN: The glycocalyx, biofilm, microbes, and resistant infection. Semin Arthroplasty 5:160-170, 1994.
14. Hanssen AD, Spangehl MJ: Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop 427:79-85, 2004.
15. Holtom PD, Pavkovic SA, Bravos PD, et al: Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. J Orthop Res 18:721-727, 2000.
16. Huddleston PM, Steckelberg JM, Hanssen AD, et al: Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg 82A:161-173, 2000.
17. Isefuku S, Joyner CJ, Simpson AH: Gentamicin may have an adverse effect on osteogenesis. J Orthop Trauma 17:212-216, 2003.
18. Isefuku S, Joyner CJ, Simpson AH: Toxic effect of rifampicin on human osteoblast-like cells. J Orthop Res 19:950-954, 2001.
19. Kadurugamuwa JL, Sin L, Albert E, et al: Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun 71:882-890, 2003.
20. Kadurugamuwa JL, Sin LV, Yu J, et al: Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection. Antimicrob Agents Chemother 47:3130-3137, 2003.
21. Mehta S, Humphrey JS, Schenkman DI, Seaber AV, Vail TP: Gentamicin distribution from a collagen carrier. J Orthop Res 14:749-754, 1996.
22. Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE: Bone toxicity of locally applied aminoglycosides. J Orthop Trauma 9:401-406, 1995.
23. Nelson CL: The current status of material used for depot delivery of drugs. Clin Orthop 427:72-78, 2004.
24. Nelson CL, Hickmon SG, Skinner RA: Treatment of experimental osteomyelitis by surgical debridement and the implantation of bioerodable, polyanhydride-gentamicin beads. J Orthop Res 15:249-255, 1997.
25. Peck KR, Kim SW, Jung SI, et al: Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis. Chemotherapy 49:189-193, 2003.
26. Pickering SA, Bayston R, Scammell BE: Electromagnetic augmentation of antibiotic efficacy in infection of orthopaedic implants. J Bone Joint Surg 85B:588-593, 2003.
27. Pilla AA: Low-intensity electromagnetic and mechanical modulation of bone growth and repair: Are they equivalent? J Orthop Sci 7:420-428, 2002.
28. Qian Z, Sagers RD, Pitt WG: Investigation of the mechanism of the bioacoustic effect. J Biomed Mater Res 44:198-205, 1999.
29. Raad I, Alrahwan A, Rolston K: Staphylococcus epidermidis: Emerging resistance and need for alternative agents. Clin Infect Dis 26:1182-1187, 1998.
30. Ramage G, Tunney MM, Patrick S, Gorman SP, Nixon JR: Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials 24:3221-3227, 2003.
31. Rediske AM, Roeder BL, Nelson JL, et al: Pulsed ultrasound enhances the killing of Escherichia coli biofilms by aminoglycoside antibiotics in vivo. Antimicrob Agents Chemother 44:771-772, 2000.
32. Springer BD, Lee GC, Osmon D, et al: Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop 427:47-51, 2004.